IOPNs lack most of the previously reported genetic alterations in IPMNs and pancreatic ductal adenocarcinomas, such as mutations in KRAS, GNAS, TP53, and RNF43 [18,38,39,40,41]. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.